News Highlights: Top Global Markets News of the Day - Monday at 9 PM ET
Stocks Extend Slump, Treasury Yields Climb
Hot monthly retail sales and Middle East tensions weigh on indexes, with the S&P 500 falling 1.2%.
Oil's rally took a breather after Iran's attack on Israel. Is $100 a barrel still in the cards?
Oil's climb toward $100 a barrel came to a halt on Monday, but whether the market is taking a temporary breather from its rally or has hit a long-term snag remains to be seen.
Gold scores another record high as market awaits Israel response to Iran attack
Gold futures eke out a gain on Monday to notch a fresh record-high settlement as traders awaited Israel's response after Iran's attack over the weekend.
Retail sales rose sharply in the first quarter - and could boost U.S. GDP
Sales at retailers rose a robust 0.7% in March and outlays in February were also stronger than initially reported, indicating the economy got a decent boost from consumer spending in the first quarter.
Israel's Next Move After Iran Attack Involves Complex Calculations
Decision makers must balance the need to deter Iran with the desire to strengthen a tenuous government coalition and achieve their war aims in Gaza.
Corporate Canada Braces for Higher Taxes in Tuesday's Budget Plan
The business groups and economists worry that higher taxes could pose another hurdle to the country's lackluster business investment.
Here's What Higher for Longer Means for the Stock Market
Stocks are still trading near record levels, but some investors say further gains may be more difficult to come by.
Trucking Oversupply Is Weighing on Carriers' Earnings Outlooks
A push by retailers and manufacturers to cut shipping costs is sending trucking industry hopes of an earnings rebound into a skid.
China's Central Bank Holds Key Policy Rates
The People's Bank of China kept key policy rates steady and drained liquidity from the banking sector as economic data shows fresh signs of weakness.
Certain Biotech Investors Get an Early Look at Results. Is That Fair?
Private investments in public equities, or PIPEs, are all the rage in biotech, but some investors resent the sharing of nonpublic information.
(END) Dow Jones Newswires
April 15, 2024 21:15 ET (01:15 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast